Literature DB >> 14983003

From conversion to aggregation: protofibril formation of the prion protein.

Mari L DeMarco1, Valerie Daggett.   

Abstract

The ability to diagnose and treat prion diseases is limited by our current understanding of the conversion process of the protein from healthy to harmful isoform. Whereas the monomeric, benign species is well characterized, the misfolded conformations responsible for infectivity and neurodegeneration remain elusive. There is mounting evidence that fibrillization intermediates, or protofibrils, but not mature fibrils or plaques, are the pathogenic species in amyloid diseases. Here, we use molecular dynamics to simulate the conversion of the prion protein. Molecular dynamics simulation produces a scrapie prion protein-like conformation enriched in beta-structure that is in good agreement with available experimental data. The converted conformation was then used to model a protofibril by means of the docking of hydrophobic patches of the template structure to form hydrogen-bonded sheets spanning adjacent subunits. The resulting protofibril model provides a non-branching aggregate with a 3(1) axis of symmetry that is in good agreement with a wide variety of experimental data; importantly, it was derived from realistic simulation of the conversion process.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14983003      PMCID: PMC356944          DOI: 10.1073/pnas.0307178101

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  61 in total

1.  Structural studies of the scrapie prion protein by electron crystallography.

Authors:  Holger Wille; Melissa D Michelitsch; Vincent Guenebaut; Surachai Supattapone; Ana Serban; Fred E Cohen; David A Agard; Stanley B Prusiner
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-12       Impact factor: 11.205

2.  Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis.

Authors:  Rakez Kayed; Elizabeth Head; Jennifer L Thompson; Theresa M McIntire; Saskia C Milton; Carl W Cotman; Charles G Glabe
Journal:  Science       Date:  2003-04-18       Impact factor: 47.728

3.  Simulations of biomolecules: Characterization of the early steps in the pH-induced conformational conversion of the hamster, bovine and human forms of the prion protein.

Authors:  Darwin O V Alonso; Chahm An; Valerie Daggett
Journal:  Philos Trans A Math Phys Eng Sci       Date:  2002-06-15       Impact factor: 4.226

Review 4.  Ideas of order for amyloid fibril structure.

Authors:  Ronald Wetzel
Journal:  Structure       Date:  2002-08       Impact factor: 5.006

5.  Monoclonal antibodies inhibit prion replication and delay the development of prion disease.

Authors:  Anthony R White; Perry Enever; Mourad Tayebi; Rosey Mushens; Jackie Linehan; Sebastian Brandner; David Anstee; John Collinge; Simon Hawke
Journal:  Nature       Date:  2003-03-06       Impact factor: 49.962

6.  Solid-state NMR studies of the secondary structure of a mutant prion protein fragment of 55 residues that induces neurodegeneration.

Authors:  D D Laws; H M Bitter; K Liu; H L Ball; K Kaneko; H Wille; F E Cohen; S B Prusiner; A Pines; D E Wemmer
Journal:  Proc Natl Acad Sci U S A       Date:  2001-09-18       Impact factor: 11.205

7.  Disease-associated F198S mutation increases the propensity of the recombinant prion protein for conformational conversion to scrapie-like form.

Authors:  David L Vanik; Witold K Surewicz
Journal:  J Biol Chem       Date:  2002-10-07       Impact factor: 5.157

8.  Amyloid fibers are water-filled nanotubes.

Authors:  M F Perutz; J T Finch; J Berriman; A Lesk
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-16       Impact factor: 11.205

9.  The role of helix 1 aspartates and salt bridges in the stability and conversion of prion protein.

Authors:  Jonathan O Speare; Thomas S Rush; Marshall E Bloom; Byron Caughey
Journal:  J Biol Chem       Date:  2003-01-27       Impact factor: 5.157

10.  Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases.

Authors:  Monica Bucciantini; Elisa Giannoni; Fabrizio Chiti; Fabiana Baroni; Lucia Formigli; Jesús Zurdo; Niccolò Taddei; Giampietro Ramponi; Christopher M Dobson; Massimo Stefani
Journal:  Nature       Date:  2002-04-04       Impact factor: 49.962

View more
  103 in total

1.  Multiple substitutions of methionine 129 in human prion protein reveal its importance in the amyloid fibrillation pathway.

Authors:  Sofie Nyström; Rajesh Mishra; Simone Hornemann; Adriano Aguzzi; K Peter R Nilsson; Per Hammarström
Journal:  J Biol Chem       Date:  2012-06-05       Impact factor: 5.157

2.  Pauling and Corey's alpha-pleated sheet structure may define the prefibrillar amyloidogenic intermediate in amyloid disease.

Authors:  Roger S Armen; Mari L DeMarco; Darwin O V Alonso; Valerie Daggett
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-27       Impact factor: 11.205

Review 3.  Prion protein at the crossroads of physiology and disease.

Authors:  Emiliano Biasini; Jessie A Turnbaugh; Ursula Unterberger; David A Harris
Journal:  Trends Neurosci       Date:  2011-12-01       Impact factor: 13.837

4.  Direct observation of multiple misfolding pathways in a single prion protein molecule.

Authors:  Hao Yu; Xia Liu; Krishna Neupane; Amar Nath Gupta; Angela M Brigley; Allison Solanki; Iveta Sosova; Michael T Woodside
Journal:  Proc Natl Acad Sci U S A       Date:  2012-03-15       Impact factor: 11.205

5.  Disruption of the X-loop turn of the prion protein linked to scrapie resistance.

Authors:  Alexander D Scouras; Valerie Daggett
Journal:  Protein Eng Des Sel       Date:  2012-03-23       Impact factor: 1.650

6.  Probing the conformation of a prion protein fibril with hydrogen exchange.

Authors:  Steven M Damo; Aaron H Phillips; Anisa L Young; Sheng Li; Virgil L Woods; David E Wemmer
Journal:  J Biol Chem       Date:  2010-08-02       Impact factor: 5.157

7.  Generation of prions in vitro and the protein-only hypothesis.

Authors:  Rodrigo Diaz-Espinoza; Claudio Soto
Journal:  Prion       Date:  2010-04-05       Impact factor: 3.931

Review 8.  Getting a grip on prions: oligomers, amyloids, and pathological membrane interactions.

Authors:  Byron Caughey; Gerald S Baron; Bruce Chesebro; Martin Jeffrey
Journal:  Annu Rev Biochem       Date:  2009       Impact factor: 23.643

Review 9.  Prion diseases and their biochemical mechanisms.

Authors:  Nathan J Cobb; Witold K Surewicz
Journal:  Biochemistry       Date:  2009-03-31       Impact factor: 3.162

10.  N-terminal Prion Protein Peptides (PrP(120-144)) Form Parallel In-register β-Sheets via Multiple Nucleation-dependent Pathways.

Authors:  Yiming Wang; Qing Shao; Carol K Hall
Journal:  J Biol Chem       Date:  2016-08-30       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.